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Abstract
The Indian buffet process (IBP) and phylogenetic Indian buffet process (pIBP) can be
used as prior models to infer latent features in a data set. The theoretical properties of
these models are under-explored, however, especially in high dimensional settings. In this
paper, we show that under mild sparsity condition, the posterior distribution of the latent
feature matrix, generated via IBP or pIBP priors, converges to the true latent feature matrix
asymptotically. We derive the posterior convergence rate, referred to as the contraction
rate. We show that the convergence holds even when the dimensionality of the latent feature
matrix increases with the sample size, therefore making the posterior inference valid in high
dimensional setting. We demonstrate the theoretical results using computer simulation, in
which the parallel-tempering Markov chain Monte Carlo method is applied to overcome
computational hurdles. The practical utility of the derived properties is demonstrated by
inferring the latent features in a reverse phase protein arrays (RPPA) dataset under the
IBP prior model. Software and dataset reported in the manuscript are provided at http:
//www.compgenome.org/IBP.
Keywords: High dimension; Indian buffet process; Latent feature; Markov chain Monte Carlo;
Posterior convergence; Reverse phase protein arrays
1 Introduction
The latent feature models are concerned about finding latent structures in a data set Xn×p where
each row xi = (xi1, · · · , xip) represents a single observation of p objects and n is the sample size.
We consider the case where the number of objects p = pn increases as sample size n increases. The
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goal is to explain the variability of the observed data with a latent binary feature matrix Zp×K
where each column of Z represents a latent feature that includes a subset of the p objects. The
number of latent features K is unknown and is inferred as well.
Bayesian nonparametric latent feature models such as the Indian buffet process (IBP) (Griffiths
and Ghahramani, 2006, 2011) can be used to define the prior distribution of the binary latent
feature matrix with arbitrarily many columns. In many applications (such as Chu et al. 2006)
these priors could lead to desirable posterior inference. An important property of IBP is that the
corresponding distribution maintains exchangeability across the rows that index the experimental
units, making posterior inference relatively simple and easy to implement. However, sometimes the
rows of the latent feature matrix must follow a group structure, such as in phylogenetic inferences.
To address such needs, the phylogenetic Indian Buffet Process (pIBP) (Miller et al., 2008) has
been developed to allow different rows to be partially exchangeable.
Despite the increasing popularity in the application of IBP and pIBP prior models, such as
in cancer and evolutional genomics, few theoretical results have been discussed on the posterior
inference based on these models. For example, from a frequentist view, it is important to investi-
gate the asymptotic convergence of the posterior distribution of the latent feature matrix under
IBP and pIBP priors. Existing literature on the theory of Bayesian posterior consistency includes,
for example, Schwartz (1965); Barron et al. (1999) and Ghosal et al. (2000). Chen et al. (2016)
is a motivational work exploring theoretical properties of the posterior distribution of the latent
feature matrix based on IBP or pIBP priors. They explored the asymptotic behavior of the IBP
or pIBP-based posterior inference, where the sample size n increases in a much faster speed than
the number of objects pn, i.e., the dimensionality of Z. This might be hard to achieve in some
real applications. We consider important extensions based on Chen et al. (2016). In particular,
we consider properties of posterior inference based on IBP and pIBP priors in high dimensions
and with sparsity. Under a similar high dimensional and sparse setting, a related work is Pati
et al. (2014), where the authors studied the asymptotic behavior of sparse Bayesian factor models
discussed in West (2003). These models are concerned about continuous latent features, which
are different from the binary feature models like IBP and pIBP.
High dimensional inference is now routinely needed in many applications, such as genomics
and proteomics. Due to the reduced cost of high-throughput biological experiments (e.g., next-
2
generation sequencing), a number of genomics elements (such as genes) can be measured with a
relatively short amount of time and low cost for a large number of patients. In our application,
the number of genomics elements n is the sample size, the number of patients p is the number of
rows, or the number of objects in the latent feature matrix, and the number of latent features K
is assumed unknown. Depending on the particular research question, in some applications, genes
can be the objects and patients can be the samples. When p = pn becomes large relative to n, the
sparsity of the feature matrix critically ensures the efficiency and validity of statistical inference.
We will show that under the sparsity condition, the requirement for posterior convergence can be
relaxed from p3n = o(n) (Chen et al., 2016) to pn(log pn)
2 = o(n) (see Remark 2).
The proposed sparsity condition can be reasonably interpreted and checked in practice. For
example, in genomics and proteomics applications, our sparsity condition means that the number
of features shared by different patients is small, i.e., the patients are heterogeneous. This is
different from some published sparsity conditions that involve more complicated mathematical
expressions, possibly in terms of the properties of complex matrices, which are difficult to check
in real-world applications.
The rest of the paper is organized as follows. Section 2 introduces the latent feature model and
the IBP/pIBP priors. Section 3 establishes the posterior contraction rate of sparse latent feature
models under IBP and pIBP prior, which is the main theoretical result of this paper. Section
4 proposes an efficient posterior inference scheme based on Markov chain Monte Carlo (MCMC)
simulations. Section 5 provides both simulated and real-world proteomics examples that support
the theoretical derivations. We conclude the paper with a brief discussion in Section 6. Some
technical details are provided in the supplement.
2 Notation and Probability Framework
In this section, we first introduce some notation, and then specify the hierarchical model including
the sampling model and the prior model. In particular, the sampling model is the latent feature
model, and the prior model is the IBP mixture or pIBP mixture.
3
2.1 Notation
Throughout the paper, we denote by p(·) and P (·) probability density functions (pdf) and proba-
bility mass functions (pmf), respectively. Specifically for the latent feature matrix Z, we use Π(Z)
and Π(Z | X) to denote the prior and posterior distribution of Z, respectively. The likelihood
p(X | Z) = ∏ni=1 p(xTi | Z). For two sequences an and bn, the notation an = O(bn) means there
exists a positive real number C and a constant n0 such that an ≤ Cbn for all n ≥ n0; the notation
an = o(bn) means for every positive real number ε there exists a constant n0 such that an ≤ εbn
for all n ≥ n0. For a matrix A, ‖A‖ denotes the spectral norm defined as the largest singular value
of A. Finally, C is a generic notation for positive constants whose value might change depending
on the context but is independent from other quantities.
2.2 Latent Feature Model
Suppose that Xn×p is a collection of the observed data. Each row xi = (xi1, · · · , xip) represents
a single observation of p objects, for i = 1, · · · , n, where xi’s are independent. Assume that the
mechanism of generating X can be characterized by latent features,
XT = ZA+ E. (1)
Here Z = (zjk)p×K denotes the latent binary feature matrix, each entry zjk ∈ {0, 1} represents
object j possesses feature k (zjk = 1) or not (zjk = 0), respectively. The loading matrix A =
(aki)K×n, with each entry being the contribution of the k-feature to the i-th observation. We
assume aki
i.i.d∼ N(0, σ2a). The error matrix E = (eji)p×n, where eji’s are independent Gaussian
errors, eji
i.i.d∼ N(0, σ2).
After integrating out A, we obtain for each observation of the p objects,
xTi
i.i.d∼ Np(0, σ2aZZT + σ2Ip),
where Np is a p-variate Gaussian distribution. Therefore, the conditional distribution of X given
Z is
p(X|Z) =
n∏
i=1
1√
(2pi)p det (σ2aZZ
T + σ2Ip)
exp
(
−1
2
xi
(
σ2aZZ
T + σ2Ip
)−1
xTi
)
. (2)
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Without loss of generality, we always assume that σ2 = σ2a = 1. One of the primary interests
is to conduct appropriate estimation on ZZT , which is usually called the similarity matrix since
each entry of ZZT is the number of features shared by two objects.
2.3 Prior Distributions Based on IBP and pIBP
In the latent feature model (Equation 1), it remains to specify the prior for the binary feature
matrix Z. IBP and pIBP are popular prior choices on binary matrices with an unbounded number
of columns. IBP assumes exchangeability among the objects, while pIBP introduces dependency
among the entries of the k-th column of Z through a rooted tree T . See Figure 1 for an example
of the tree. IBP is a special case of pIBP when the root node is the only internal node of the
tree. The construction and the pmf of IBP are described and derived in detail in Griffiths and
Ghahramani (2011). For pIBP, only a brief definition is given in Miller et al. (2008). For the proof
of the main theoretical result of this paper, we propose a construction of pIBP in a similar way
as IBP and derive the pmf of pIBP.
We first introduce some notation. Let Zp×K denote the collection of binary matrices with p rows
and K (K ∈ N+) columns such that none of these columns consist of all 0’s. Let Zp = ∪∞K=1Zp×K
and let 0 denote a p-dimensional vector whose elements are all 0’s, i.e.,
0 = (0, 0, · · · , 0)T .
In the following sections, we also regard 0 as a p × 1 matrix when needed. Both IBP and pIBP
are defined over Z0p , {0}
⋃Zp. It can be shown that with probability 1, a draw from IBP
or pIBP has only finitely many columns. For the construction of IBP and pIBP, we introduce
some more notations as follows. Denote by Z˜p×K˜ the collection of all binary matrices with p
rows and K˜ columns (where the columns can be all zeros). We define a many-to-one mapping
G(·) : Z˜p×K˜ → Z0p . For a binary matrix Z˜ ∈ Z˜p×K˜ , if all columns of Z˜ are 0’s, then G(Z˜) = 0;
otherwise, G(Z˜) is obtained by deleting all zero columns of Z˜. For the purpose of performing
inference on the similarity matrix ZZT , it suffices to focus on the set of equivalence classes induced
by G(·). Two matrices Z˜1, Z˜2 ∈ Z˜p×K˜ are G-equivalent if G(Z˜1) = G(Z˜2), and in this case the
similarity matrices induced by Z˜1 and Z˜2 are the same, Z˜1Z˜
T
1 = Z˜2Z˜
T
2 .
We now turn to a constructive definition of pIBP. The pIBP can be constructed in the following
three steps by taking the limit of a finite feature model.
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Step 1. Given some hyperparameter α and tree structure T , we start by defining a probability dis-
tribution PK˜(Z˜ | α, T ) over Z˜ ∈ Z˜p×K˜ . Denote by Z˜ = (z˜1, z˜2, · · · , z˜K˜). Let pi = {pi1, pi2, · · · , piK˜}
be a vector of success probabilities such that (pik | α) i.i.d.∼ Beta(α/K˜, 1). The columns of Z˜ are
conditionally independent given pi and T ,
PK˜(Z˜ | pi, T ) =
K˜∏
k=1
P (z˜k | pik, T ),
where P (z˜k | pik, T ) is determined as in Miller et al. (2008) (more details in Supplementary Section
S1). If P (z˜k | pik, T ) =
∏p
j=1 P (z˜jk | pik) where z˜jk i.i.d∼ Bernoulli(pik), pIBP reduces to IBP. The
marginal probability of Z˜ is
PK˜(Z˜ | α, T ) =
K˜∏
k=1
∫
P (z˜k | pik, T )p(pik | α)dpik.
Step 2. Next, for any Z ∈ Z0p with K columns, we define a probability distribution (for K˜ ≥ K)
ΠK˜(Z | α, T ) ,
∑
Z˜∈Z˜p×K˜ :G(Z˜)=Z
PK˜(Z˜ | α, T ),
for PK˜(Z˜ | α, T ) defined in Step 1. That is, we collapse all binary matrices in Z˜p×K˜ that are
G-equivalent.
Step 3. Finally, for any Z ∈ Z0p , define
Π(Z | α, T ) , lim
K˜→∞
ΠK˜(Z | α, T ).
Here Π(Z | α, T ) is the pmf of pIBP under G-equivalence classes.
Based on the three steps of constructing pIBP, we derive the pmf of pIBP given α and T .
Details on the derivation is given in Supplementary Section S1. Let S(T ) denote the total edge
lengths of the tree structure (see Figure 1) and ψ(·) denote the digamma function. For Z ∈ Z0p ,
we have
Π(Z | α, T ) =

exp {− (ψ (S(T ) + 1)− ψ(1))α} , if Z = 0;
exp {− (ψ (S(T ) + 1)− ψ(1))α} αK
K!
K∏
k=1
λk, if Z ∈ Zp×K ,
(3)
where λk , λ(zk, T ) =
∫ 1
0
P (zk | pik, T )pi−1k dpik (See Supplementary Section S1) and zk is the k-th
column of Z.
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Assume α ∼ Gamma(1, 1). After integrating out α, we obtain the pmf of pIBP mixture,
Π(Z | T ) =

(
ψ(S(T ) + 1)− ψ(1) + 1
)−1
, if Z = 0;(
ψ(S(T ) + 1)− ψ(1) + 1
)−(K+1) K∏
k=1
λk, if Z ∈ Zp×K .
For notational simplicity, we suppress the condition on T hereafter when we discuss pIBP.
When S(T ) = p and λk =
∫ 1
0
∏p
j=1 pi
mk−1
k (1 − pik)p−mkdpik, pIBP reduces to IBP, where mk =∑p
j=1 zjk denotes the number of objects possessing feature k. The pmf of IBP mixture is
Π(Z) =
(Hp + 1)
−1, if Z = 0;
(Hp + 1)
−(K+1)∏K
k=1
(p−mk)!(mk−1)!
p!
, if Z ∈ Zp×K ,
where Hp =
∑p
j=1(1/j).
Root
ζ1
ζ2
ζ3
ζ4
ζ5
ζ6
ξ1
Leaves
z1,k
z2,k
z3,k
z4,k
z5,k
z6,k
z7,k
z8,k
z9,k
z10,k
z11,k
z12,k
t1
t2
t3
t4
t5
t6
η1
η1
η2
η3
η3
η3
η4
η5
η5
η5
η5
η6
Figure 1: An example of a tree structure T , which is a directed graph with random variables at
the nodes (marked as circles). Entries of the k-th column of Z, zjk’s, are at the leaves. The lengths
of all edges of T , ti’s and ηl’s, are marked on the figure. In particular, ηl’s represent the lengths
between each leaf (zjk, in black) and its parent node (ζl, in red). The total edge lengths S(T ) is
the summation of the lengths of all edges of T . In this example, S(T ) = ∑1≤i≤6 ti + (2η1 + η2 +
3η3 + η4 + 4η5 + η6). The condition in case (2) of Lemma 1 in Section 3 means inf
1≤l≤6
ηl ≥ η0 for
some η0 > 0.
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3 Posterior Contraction Rate under the Sparsity Condi-
tion
In this section, we establish the posterior contraction rate of IBP mixture and pIBP mixture under
a sparsity condition. All the proofs are given in the supplement.
The sparsity condition is defined below for a sequence of binary matrices {Z∗n, n = 1, 2, . . .}.
Definition 1 (Sparsity). Consider a sequence of binary matrices {Z∗n, n = 1, 2, . . .} where Z∗n =
(z∗jk)pn×K∗n . Assume that mkn ,
∑pn
j=1 z
∗
jk ≤ sn for some sn ≥ 1 and all k = 1, . . . , K∗n. We say
{Z∗n, n = 1, 2, . . .} are sparse if sn/pn → 0 as n→∞.
The condition indicates that as sample size increases, the number of objects possessing any
feature is upper-bounded and must be relatively small compared to the total number of objects.
Therefore, such an assumption may be assessed via simulation studies and then applied to real-
world applications. Examples will be provided later on. Similar but more strict assumptions are
made in Castillo et al. (2012) and Pati et al. (2014), under different contexts.
Next, we review the definition of posterior contraction rate.
Definition 2 (Posterior Contraction Rate). Let {Z∗n, n = 1, 2, . . .} represent a sequence of
true latent feature matrices where each Z∗n has pn rows. For each n, the observations are generated
from xTi
i.i.d.∼ N(0, Z∗nZ∗Tn + Ipn) for i = 1, 2, · · · , n. Denote by Π(· | X) the posterior distribution
of the latent feature matrix under IBP mixture or pIBP mixture prior. If
EZ∗n
[
Π
(‖ZnZTn − Z∗nZ∗Tn ‖ ≤ Cn | X)]→ 1
as n→∞, where ‖ · ‖ represents the spectral norm and C is a positive constant, then we say the
posterior contraction rate of ZnZ
T
n to the true Z
∗
nZ
∗T
n is n under the spectral norm.
For the proof of the main theorem, we derive the following lemma. The lemma establishes the
lower bound of Π(Zn = Z
∗
n) for a sequence of binary matrices {Z∗n, n = 1, 2, . . .} satisfying the
sparsity condition, where Π(·) represents the pmf of IBP mixture or pIBP mixture.
Lemma 1. Consider a sequence of binary matrices {Z∗n : Z∗n ∈ {0}
⋃Zpn×K∗n , n = 1, 2, . . .} that
are sparse under Definition 1. Parameters mkn and sn are defined accordingly (for 0 matrices, let
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sn = K
∗
n = 1). We have
Π(Zn = Z
∗
n) ≥ exp (−CsnK∗n log(pn + 1))
for some positive constant C, if either of the following two cases is true: (1) Zn follows IBP
mixture; (2) Zn follows pIBP mixture, and the minimal length between each leaf and its parent
node is lower bounded by η0 > 0 (see Figure 1).
Remark 1. Results in Lemma 1 depend on the sparsity condition. As a counterexample, we
approximate Π(Zn = Z
∗
n) for a sequence of non-sparse binary matrices {Z∗n, n = 1, 2, . . .}, where
Z∗n ∈ Zpn , and Zn follows IBP mixture. Recall that for IBP mixture, we have
Π(Zn = Z
∗
n) =
1
(Hpn + 1)
K∗n+1
K∗n∏
k=1
(pn −mkn)!(mkn − 1)!
pn!
.
Letmkn = pn/2 for every column k = 1, . . . , K
∗
n, then [(pn−mkn)!(mkn−1)!]/(pn!) = [(pn/2)!(pn/2−
1)!]/(pn!) and Stirling’s formula implies that [(pn/2)!(pn/2 − 1)!]/(pn!) ∼
√
2pi/pn 2
−pn . Since
Hpn = log pn +O(1),
Π(Zn = Z
∗
n) ≤ exp(−CK∗n log log(pn + 2))
(
C
√
2pi
pn
1
2pn
)K∗n
≤ exp(−CK∗npn).
Comparing the results obtained with and without sparsity conditions, we find the lower-bound
with sparsity condition is very likely to be larger than the upper-bound without sparsity condition.
To consider a very extreme case, when sn = log(pn+1), the lower-bound exp(−CK∗n(log(pn+1))2)
is much larger than exp(−CK∗npn).
We present the main theorem of this paper, which proves that for a sequence of true latent
feature matrix Z∗n that satisfy the sparsity condition in Definition 1, the posterior distribution
of the similarity matrix ZnZ
T
n converges to Z
∗
nZ
∗T
n . The theorem eventually leads to the main
theoretical result in Remark 2 later.
Theorem 1. Consider a sequence of sparse binary matrices {Z∗n, n = 1, 2, . . .} as in Definition
1 and the prior in either of the two cases of Lemma 1. For each n, suppose the observations are
generated from xTi
i.i.d.∼ N(0, Z∗nZ∗Tn + Ipn) for i = 1, 2, · · · , n. Let
n =
max
{√
pn,
√
snK∗n log(pn + 1)
}
√
n
max{1, ‖Z∗nZ∗Tn ‖}.
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If n → 0 as n→∞, then we have
EZ∗n
[
Π
(‖ZnZTn − Z∗nZ∗Tn ‖ ≤ Cn | X)]→ 1
as n→∞ for some positive constant C. In other words, n is the posterior contraction rate under
the spectral norm.
For the sequence of sparse binary matrices {Z∗n, n = 1, 2, . . .} considered in Theorem 1, if
‖Z∗nZ∗Tn ‖ ≤Mn for some Mn ≥ 1 and ˜n ,
max
{√
pn,
√
snK∗n log(pn+1)
}
√
n
Mn → 0 as n→∞, then ˜n is a
valid posterior contraction rate. We show in the following corollary that if the number of features
possessed by each object is upper bounded, then a new posterior contraction rate with a simpler
expression (compared to Theorem 1) can be derived.
Corollary 1. Consider a sequence of sparse binary matrices {Z∗n, n = 1, 2, . . .} as in Definition 1
where Z∗n = (z
∗
jk)pn×K∗n. Suppose that there exists qn ≥ 1 such that
sup
1≤j≤pn
( K∗n∑
k=1
z∗jk
)
≤ qn,
i.e., the number of features possessed by each object (non-zero entries of each row of Z∗n) is upper
bounded by qn. Given the same assumptions in Theorem 1 except for replacing n → 0 by
˜n ,
max
{√
pn,
√
snK∗n log(pn + 1)
}
√
n
snqn → 0
as n→∞, we have
EZ∗n
[
Π
(‖ZnZTn − Z∗nZ∗Tn ‖ ≤ C˜n | X)]→ 1
as n→∞ for some positive constant C. Specifically,
1. if there is no additional condition on qn,
˜n =
max
{√
pn,
√
snK∗n log(pn + 1)
}
√
n
snK
∗
n;
2. if qn is a constant,
˜n =
max
{√
pn,
√
snK∗n log(pn + 1)
}
√
n
sn.
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Remark 2. Consider the second case of Corollary 1. If (1) snK
∗
n log(pn + 1) = O(pn) and (2)
sn = O(log(pn+1)), then ˜n ≤ C
√
pn log(pn+1)√
n
; therefore, if pn(log(pn+1))
2 = o(n), then
√
pn log(pn+1)√
n
is a valid posterior contraction rate. In other words, to ensure posterior convergence, we only need
n to increase a little bit faster than pn, given the assumptions (1), (2) and the condition in the
second case of Corollary 1.
4 Posterior Inference Based on MCMC
We have specified the hierarchical models including the sampling model p(X | Z) and the prior
models for the parameters Π(Z | α) and p(α). In particular, p(X | Z) is the latent feature model
(Equation 2), Π(Z | α) is the IBP or pIBP prior (Equation 3) and p(α) = Gamma(1, 1). For the
theoretical results in Section 3, we integrate out α. For posterior inference, we keep α so that the
conditional distributions can be obtained in closed form.
We use Markov chain Monte Carlo simulations to generate samples from the posterior (Z, α) ∼
Π(Z, α | X) ∝ p(X | Z)Π(Z | α)p(α). After iterating sufficiently many steps, the samples of
Z drawn from the Markov chain approximately follow Π(Z | X). Gibbs sampling transition
probabilities can be used to update Z and α, as described in Griffiths and Ghahramani (2011)
and Miller et al. (2008).
To overcome trapping of the Markov chain in local modes in the high-dimensional setting, we
use parallel tempering Markov chain Monte Carlo (PTMCMC) (Geyer, 1991) in which several
Markov chains at different temperatures run in parallel and interchange the states across each
other. In particular, the target distribution of the Markov chain indexed by temperature T is
Π(T )(Z, α | X) ∝ p(X | Z) 1T Π(Z | α)p(α).
Parallel tempering helps the original Markov chain (the Markov chain whose temperature T is 1)
avoid getting stuck in local modes and approximate the target distribution efficiently.
We give an algorithm below for sampling from Π(Z, α | X) where Π(Z | α) follows IBP. The
algorithm describes in detail how PTMCMC can be combined with the Gibbs sampler in Griffiths
and Ghahramani (2011). The algorithm iterates Step 1 and Step 2 in turn.
Step 1 (Updating Z and α). Denote by zjk the entries of Z, j = 1, . . . , p and k = 1, . . . , K.
We update Z by row. For each row j, we iterate through the columns k = 1, . . . , K. We first
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make a decision to drop the k-th column of Z, zk, if and only if m(−j)k =
∑
j′ 6=j zj′k = 0. In other
words, if feature k is not possessed by any object other than j, then the k-th column of Z should
be dropped, regardless of whether zjk = 0 or 1.
If the k-th column is not dropped, we sample zjk from
Π(T )(zjk | . . .) ∝ p(X | Z) 1T Π(zjk | Z(−jk), α),
where Z(−jk) represents all entries of Z except zjk and P (X | Z) is determined by xTi | Z i.i.d.∼
N(0, ZZT +Ip), in which xi’s are rows of X. The conditional prior Π(zjk | Z(−jk), α) only depends
on z(−j)k (i.e., the k-th column of Z excluding zjk). Specifically,
Π(zjk = 1 | Z(−jk), α) =
m(−j)k
p
.
After updating all entries in the j-th row, we add a random number of K+j columns (features)
to Z. The K+j new features are only possessed by object j, i.e. only the j-th entry is 1 while
all other entries are 0. Let Z+ denote the feature matrix after K
+
j columns are added to the old
feature matrix. The conditional posterior distribution of K+j is
P (T )(K+j | . . .) ∝ p(X | Z+)
1
T P (K+j | α),
in which P (K+j | α) is the prior distribution of K+j under IBP, P (K+j | α) = Pois (α/p). The sup-
port of P (T )(K+j | . . .) is N. For easier evaluation of P (T )(K+j | . . .), we work with an approximation
by truncating P (T )(K+j | . . .) at level K+max, similar to the idea of truncating a stick-breaking prior
in Ishwaran and James (2001). The value K+max is the maximum number of new columns (features)
that can be added to Z each time we update the j-th row. Denote by P˜ (T )(K+j | . . .) the truncated
conditional posterior, we have
P˜ (T )(K+j = k | . . .) =
P (T )(k | . . .)∑K+max
k′=0 P
(T )(k′ | . . .)
, for k = 0, 1, · · · , K+max. (4)
Lastly, we update α. Given Z, the observed data X and α are conditionally independent,
which implies that the conditional posterior distribution of α at any temperature T is the same.
We sample α from
(α | . . .) ∼ Gamma
(
K + 1,
( p∑
j=1
1
j
+ 1
)−1)
.
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Step 2 (Interchanging States across Parallel Chains). We sort the Markov chains in de-
scending order by their temperatures T . The next step of PTMCMC is interchanging states
between adjacent Markov chains. Let
(
Z(T ), α(T )
)
denote the state of the Markov chain in-
dexed by temperature T . Suppose we run N parallel chains with descending temperatures
TN , TN−1, . . . , T2, T1, where T1 = 1. Sequentially for each i = N,N − 1, . . . , 2, we propose an
interchange of states between
(
Z(Ti), α(Ti)
)
and
(
Z(Ti−1), α(Ti−1)
)
and accept the proposal with
probability
ATi,Ti−1 = min
{(p(X | Z(Ti−1))
p(X | Z(Ti))
) 1
Ti
− 1
Ti−1 , 1
}
.
5 Examples
5.1 Simulation Studies
We conduct simulation to examine the convergence of the posterior distribution of ZnZ
T
n (under
IBP mixture prior) to the true similarity matrix Z∗nZ
∗T
n . We consider several true similarity
matrices with different sample sizes n’s and explore the contraction of the posterior distribution.
Hereinafter, we suppress the index n.
Simulations under the Sparsity Condition of Z∗
In this simulation, the true latent feature matrix, Z∗ = (z∗jk)p×K∗ , is randomly generated under
the sparsity condition in Definition 1 (i.e., mk ≤ s for k = 1, . . . , K∗, where s is relatively small
compared with p). We set s = 10, K∗ = 10 and p = 50, 100, or 150. We use s/p to measure the
sparsity (as in Definition 1).
Once Z∗ is generated, the samples x1,x2, · · · ,xn are generated under the sampling model
(Equation 2) with
xTi
i.i.d.∼ N(0, Z∗Z∗T + Ip),
where xi’s are rows of X. For each value of p, we conduct 4 simulations, with sample sizes
n = 20, 50, 80 or 100.
Given simulated data X, we use the proposed PTMCMC algorithm introduced in Section 4 to
sample from the posterior distribution Π(Z | X), setting K+max in (4) at 10. We set the number
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of parallel Markov chains N = 11 with geometrically spaced temperatures. Namely, the ratio
between adjacent temperatures β , Ti+1/Ti = 1.2, with T1 = 1. We run 1, 000 MCMC iterations.
The chains converge quickly and mix well based on basic MCMC diagnostics.
We repeat the simulation scheme 40 times, each time generating a new data set with a new
random seed and applying the PTMCMC algorithm for inference. We report two summaries in
Table 1 based on the 40 simulation studies. The entries are the true values of (n, p) (first column),
p/n (second column), average (across the 40 simulation studies) of the 1, 000-th MCMC value of
K (third column), average residual ‖ZZT − Z∗Z∗T‖ (across the 40 simulation studies) based on
the 1, 000-th MCMC value of Z (fourth column).
For fixed p, ZZT converges to Z∗Z∗T as sample size increases. When n = 100, ‖ZZT −Z∗Z∗T‖
is very close to 0 and K is close to the truth K∗ = 10. On the other hand, for fixed n, increasing p
does not make the posterior distribution of ZZT significantly less concentrated at the true Z∗Z∗T ,
implying that the inference is robust to high-dimensional matrix of Z as long as the true matrix
Z∗ is sparse. This verifies the theoretical results we have reported early on.
Sensitivity of Sparsity
In this part, we use simulation results to demonstrate the effect of sparsity of Z∗ in the posterior
convergence. We set p = 50, K∗ = 10 and n = 100, and use different s = 10, 15, 18, 20, 23, 25,
reducing the sparsity of Z∗ gradually. We generate Z∗ and X the same way as in the previous
simulation. We set the number of parallel Markov chains N = 11 and K+max = 10. To increase the
frequency of interchange between adjacent chains, we reduce β to 1.15.
Table 2 reports the simulation results. As Z∗ becomes less sparse, the posterior distribution
of Z becomes less concentrated on Z∗, in terms of both K and ‖ZZT − Z∗Z∗T‖. Specifically, for
s ∈ {15, 20, 25}, when s increases by 5, ‖ZZT − Z∗Z∗T‖ inflates more than 10 fold.
5.2 Application for Proteomics
We apply the binary latent feature model to the analysis of a reverse phase protein arrays
(RPPA) dataset from The Cancer Genome Atlas (TCGA, https://tcga-data.nci.nih.gov/
tcga/) downloaded by TCGA Assembler 2 (Wei et al., 2017). The RPPA dataset records the lev-
els of protein expression based on incubating a matrix of biological samples on a microarray with
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(n, p) p/n Ksd ‖ZZT − Z∗Z∗T‖sd
(20, 50) 2.5 13.5502.385 16.3495.315
(50, 50) 1 10.7000.791 3.4442.205
(80, 50) 0.625 10.3000.564 0.5911.117
(100, 50) 0.5 10.2750.506 0.4780.951
(20, 100) 5 12.6501.718 12.5053.029
(50, 100) 2 10.7500.776 3.4951.552
(80, 100) 1.25 10.2750.506 0.7091.315
(100, 100) 1 10.2500.494 0.3430.734
(20, 150) 7.5 12.6002.073 11.3392.618
(50, 150) 3 10.6750.797 3.3871.876
(80, 150) 1.875 10.2820.456 0.4720.884
(100, 150) 1.5 10.2500.439 0.2500.439
Table 1: Simulation results based on the sample value of K and Z from the 1, 000-th MCMC
iteration. Entries in normal size and in the subscript (columns 3 and 4) are the averages and
standard deviations of 40 independent simulation studies.
s s/p Ksd ‖ZZT − Z∗Z∗T‖sd
10 0.2 10.2250.480 0.2000.405
15 0.3 10.1000.304 0.1000.304
18 0.36 10.2250.423 1.2125.454
20 0.4 10.2750.554 1.9595.146
23 0.46 10.8500.802 20.19226.867
25 0.5 11.1500.736 24.55219.141
Table 2: The true(n, p,K∗) = (100, 50, 10). Simulation results based on the sample value of K
and Z from the 1, 000-th MCMC iteration. Entries in normal size and in the subscript (rows 3
and 4) are the average and standard deviations of 40 independent simulation studies.
15
specific antibodies that target corresponding proteins (Sheehan et al., 2005; Spurrier et al., 2008).
We focus on patients categorized as 5 different cancer types, including breast cancer (BRCA),
diffuse large B-cell lymphoma (DLBC), glioblastoma multiforme (GBM), clear cell kidney carci-
noma (KIRC) and lung adenocarcinoma (LUAD). Data of n = 157 proteins are available. We
randomly choose p = 100 patients for our analysis, with an equal number of 20 patients for each
cancer type. Note that we consider proteins as experimental units and patients as objects in the
data matrix with an aim to allocate latent features to patients (not proteins). This will be clear
later when we report the inference results. The rows of the data matrix Xn×p are standardized,
with
∑p
j=1 xij = 0 for i = 1, . . . , n. Since the patients are from different cancer types, we expect
the data to be highly heterogeneous and the number of common features that two patients share
to be small, i.e the feature matrix is sparse.
LU
AD
KI
RC
GB
M
DL
BC
BR
CA
Figure 2: The inferred binary feature matrix Zˆ for the TCGA RPPA dataset. The dataset consists
of 100 patients, with 20 patients for each of the 5 cancer type, BRCA, DLBC, GBM, KIRC and
LUAD. A shaded gray rectangle indicates the corresponding patient j possesses feature k, i.e. the
corresponding matrix element Zˆjk = 1. The columns are in descending order of the number of
objects possessing each feature. The rows are reordered for better display.
We fit the binary latent feature model under the IBP prior Π(Z | α) and α ∼ Gamma(1, 1).
In addition, rather than fixing σ2 = σ2a = 1, we now assume inverse-Gamma distribution priors
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on them, σ2 ∼ IG(1, 1) and σ2a ∼ IG(1, 1). We run 1,000 MCMC iterations, as in the simulation
studies. We also repeat the MCMC algorithm 3 times with different random seeds and do not
observe substantial difference across the runs. We report point estimates (Zˆ, αˆ, σˆ2, σˆ2a) according
to the maximum a posteriori (MAP) estimate,
(Zˆ, αˆ, σˆ2, σˆ2a) = arg max
(Z,α,σ2,σ2a)
p(Z, α, σ2, σ2a | X).
Figure 2 shows the inferred binary feature matrix Zˆ, where a shaded gray rectangle indicates
the corresponding patient j possesses feature k. For the real data analysis we do not know the
true latent feature matrix and its sparsity, but can use the estimated Zˆ to approximate the
truth. From the Zˆ matrix, we find that a feature is possessed by at most sˆ = 31 patients, and
therefore the sparsity of Zˆ is about sˆ/p = 0.31. If the estimated sparsity is close to the truth,
according to simulation results (Section 5.1 Table 2), the posterior distribution of Z should be
highly concentrated at the truth Z∗.
Biological Interpretation of the Features
We report the unique genes for the top 10 proteins that have the largest loading values aˆki
for the five most popular features. That is, for the top five features k possessed by the largest
numbers of patients (the first five columns in Figure 2), we report the proteins with the largest aˆki
values. The aˆki values are posterior mean from the MCMC samples, in which parameters aki’s are
sampled from their full conditional distributions. This additional sampling step for aki’s is added
to the proposed PTMCMC algorithm for the purpose of assessing the biological implication of the
features. It is a simple Gibbs step as the full conditional distributions of aki’s are known Gaussian
distributions. Table S1 in the supplement lists these genes and their feature membership. We
conduct the gene set enrichment analysis (GSEA) in Subramanian et al. (2005) comparing the
genes in each feature with pathways from the Kyoto Encyclopedia of Genes and Genomes (KEGG)
database (Kanehisa and Goto, 2000). The GSEA analysis reports back the enriched pathways and
the corresponding genes, which is listed in Table S2 in the supplement. We observe the following
findings.
Feature 1. Among all the features, only genes in feature 1 are enriched in the cell cycle
pathway. They are also enriched in the p53 signaling pathway. This indicates that feature 1
might be related to cell death and cell cycle. Feature 2. Feature 2 is enriched in many different
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types of pathways, which may be caused by its two key gene members: NRAS:4893 (oncogene)
and PTEN:5728 (tumor suppressor). These two genes play key roles in the PI3K-Akt signaling
pathway and also regulate many other cancer-related pathways. Feature 3. Genes in feature 3 are
enriched in inflammation related pathways, such as the non-alcoholic fatty liver disease, Hepatitis
B, viral carcinogenesis, hematopoietic cell lineage and phagosome pathways. This means feature
3 is mostly related to inflammation. Feature 4 and 5. Genes in features 4 and 5 are enriched in
the largest number of pathways that are similar, with the exception of the p53 pathway (enriched
with feature 4 but not 5) and the Jak-STAT signaling pathway (enriched with feature 5 but not 4).
This indicates that feature 4 is more related to intracellular factors like DNA damage, oxidative
stress and activated oncogenes, while feature 5 is more related to extracellular factors such as
cytokines and growth factors.
Depending on the possession of the first five features, the patients in each cancer type can be
further divided into potential molecular subgroups. For example, most BRCA patients possess
features 1, 2 or 3, which indicate that these tumors are related to cell death and cell cycle (features
1 & 2), or inflammation (feature 3) pathways; most of the GBM and KIRC patients possess features
1, 2, 3 or 4, indicating an additional subgroup of patients with tumor associated to DNA damage
(feature 4). The DLBC patients are highly heterogeneous, as many of them do not possess any of
the first five main features. This has been well recognized in the literature (Zhang et al., 2013).
Lastly, LUAD seems to have two subgroups, possessing mostly feature 1 or 2, respectively. They
correspond to cell death and cell cycle functions, which suggest that these two subgroups of cancer
could be related to abnormal cell death and cell cycle regulation.
We also note that there are other informative features besides the five mentioned above. For
example, feature 16 is only possessed by BRCA patients, in which the top genes include ESR1, AR,
GATA3, AKT1, CASP7, ETS1, BCL2, FASN and CCNE2, all of which have been shown closely
related to breast cancer (see Clatot et al. (2017); Cochrane et al. (2014); Takaku et al. (2015); Ju
et al. (2007); Chaudhary et al. (2016); Furlan et al. (2014); Dawson et al. (2010); Menendez and
Lupu (2017); Tormo et al. (2017)).
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6 Conclusion and Discussion
Our main contributions in this paper are (1) reducing the requirement on the growth rate of sample
size with respect to dimensionality that ensures posterior convergence of IBP mixture or pIBP
mixture under proper sparsity condition, (2) proposing an efficient MCMC scheme for sampling
from the model, and (3) demonstrating the practical utility of the derived properties through an
analysis of an RPPA dataset. The sparsity condition is mild and interpretable, making real-case
applications possible. This result guarantees the validity of using IBP mixture or pIBP mixture
for posterior inference in high dimensional settings theoretically.
There are several directions along which we plan to investigate further. First, since the as-
sumptions made on the true latent feature matrix Z∗n are quite mild, the posterior convergence
in Theorem 1 only holds when pn = o(n). It is of interest whether posterior convergence still
holds when pn increases faster, e.g., pn  n. As a trade-off, results with a faster-increasing pn
would likely require additional assumptions on Z∗n, such as the Assumption 3.2 (A3) in Pati et al.
(2014). It is also of interest to explore whether the contraction rate in Theorem 1 can be further
improved with additional assumptions. This is closely related to the problem of minimax rate
optimal estimators for Z∗nZ
∗
n
T , or more broadly, the covariance matrix of random samples, which
has been partially addressed in Pati et al. (2014).
Another potential direction for further investigation is to extend the latent feature model (1)
to a more general latent factor model, in which the binary matrix Z is replaced with a real-valued
factor matrix G. The binary matrix Z is then used to indicate the sparsity of G. See, e.g., Knowles
and Ghahramani (2011). To prove posterior convergence for such a model, Lemma 1 needs to be
modified based on the factor loading matrix, such as Lemma 9.1 in Pati et al. (2014).
Throughout this paper we measure the difference between the similarity matrices by the spec-
tral norm. Other matrix norms, such as the Frobenius norm, may be explored. Our current results
focus on the posterior convergence of ZnZ
T
n rather than Zn itself due to the identifiability issue of
Zn arose from (2). A future direction is to investigate to what extent can Z
∗
n be estimated, and a
Hamming distance like measure between the feature matrices can be considered.
Finally, we are working on general hierarchical models that embed sparsity into the model
construction.
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Supplementary Materials
S1 Derivation of the PMF of pIBP
In Step 1 of the construction of pIBP, recall
PK˜(Z˜ | α, T ) =
K˜∏
k=1
∫
P (z˜k | pik, T )p(pik | α)dpik.
Here P (z˜k | pik, T ) is defined by the universal tree structure T for any k = 1, . . . , K˜ according to
Miller et al. (2008).
Denote by z˜k = (z1k, z2k, · · · , zpk)T . For each k, we treat the tree as a directed graph with
random variables at the interior nodes and zjk’s at the leaf nodes, j = 1, . . . , p. See Figure S1.
Given pik, for any variable x at the parent node (including the root node) and any variable y at
the child node (including the leaf node, in which case y = zjk), if the edge between x and y has
length t, then
P (y = 0 | x = 0, pik) = exp(−γkt),
P (y = 1 | x = 0, pik) = 1− exp(−γkt),
P (y = 0 | x = 1, pik) = 0,
P (y = 1 | x = 1, pik) = 1,
(S1)
where γk = − log(1− pik). The value of the random variable at the root node is always fixed at 0.
The joint distribution of all random variables on the tree (nodes and leaves) is uniquely defined
by the conditional probabilities (see Figure S1). So is P (z˜k | pik, T ). Note that given pi and T ,
the columns of Z˜ are conditionally independent, i.e. PK˜(Z˜ | α, T ) is column-exchangeable. If Z˜1
is generated by permuting columns of Z˜, then PK˜(Z˜ | α, T ) = PK˜(Z˜1 | α, T ).
In Step 2, for Z ∈ Z0p with K columns,
ΠK˜(Z | α, T ) ,
∑
Z˜∈Z˜p×K˜ :G(Z˜)=Z
PK˜(Z˜ | α, T ) =
(
K˜
K
)
PK˜(Z˜∗ | α, T ),
where Z˜∗ is such that the first K columns of Z˜∗ are exactly the same with Z and the rest K˜ −K
columns are all 0. For notational simplicity we still denote Z˜∗ by Z˜.
In Step 3, to obtain the pmf Π(Z | α, T ), we take the limit limK˜→∞ΠK˜(Z | α, T ). We consider
two cases (1) Z ∈ Zp and (2) Z = 0.
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Figure S1: An example of a tree structure T , which is a directed graph with random variables
(ξ’s, ζ’s and z’s) at the nodes. In particular, entries of the k-th column of Z, zjk’s, are at the
leaves. The length of the edge between ζ4 and ξ1 is t1, and similarly for t2 and η3. The total
edge length from the root to any leaf is always equal to 1. For example, t1 + t2 + η3 = 1. Thus
S(T ) ≤ p. Conditional probabilities (S1) imply that once the variable at a node becomes 1, all
its child nodes (including leaf nodes) become 1. Solid circles represent that the variables at the
corresponding positions are 1. Hollow circles denote 0’s. Bold segments are drawn for the edges
connecting 1’s. The leaves are divided into 6 subgroups according to their common parent nodes
ζl’s.
We first consider Z ∈ Zp. Denote by Z = (z1, z2, · · · , zK), we have
ΠK˜(Z | α, T )
=
K˜!
K!(K˜ −K)!PK˜(Z˜ | α, T )
=
K˜!
K!(K˜ −K)!
K∏
k=1
∫
P (zk | pik, T )p(pik | α)dpik︸ ︷︷ ︸
P1,K˜(Z˜|α,T )
·
K˜∏
k>K
∫
P (0 | pik, T )p(pik | α)dpik︸ ︷︷ ︸
P2,K˜(Z˜|α,T )
.
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We consider P1,K˜(Z˜ | α, T ) and P2,K˜(Z˜ | α, T ) separately. For P1,K˜(Z˜ | α, T ), we define
λ(zk, T ) , lim
K˜→∞
∫ 1
0
P (zk | pik, T )pi
α
K˜
−1
k dpik =
∫ 1
0
P (zk | pik, T )pi−1k dpik, (S2)
where λ(zk, T ) <∞ for zk 6= 0. Thus,
lim
K˜→∞
P1,K˜(Z˜ | α, T ) = lim
K˜→∞
K˜!
K!(K˜ −K)! · (
α
K˜
)K ·
K∏
k=1
∫ 1
0
P (zk | pik, T )pi
α
K˜
−1
k dpik
= lim
K˜→∞
K˜!
(K˜ −K)!K˜K ·
αK
K!
·
K∏
k=1
∫ 1
0
P (zk | pik, T )pi
α
K˜
−1
k dpik
= 1 · α
K
K!
·
K∏
k=1
λ(zk, T ). (S3)
For P2,K˜(Z˜ | α, T ), we need to calculate P (0 | pik, T ). In the case that the variables at the
leaves zk = 0, the random variables at all nodes of the tree must take value 0 (see Figure S1).
Based on equations (S1), we calculate
P (0 | pik, T ) =
∏
t∈edges of T
exp(−γkt) = exp(−γk
∑
t∈edges of T
t) = (1− pik)S(T )
where γk = − log(1− pik) and S(T ) is defined as the total edge lengths of T . Accordingly,∫
P (0 | pik, T )p(pik | α)dpik =
∫
P (0 | pi, T )p(pi | α)dpi = α
K˜
∫ 1
0
(1− pi)S(T )pi αK˜−1dpi.
Thus
P2,K˜(Z˜ | α, T ) =
(∫
P (0 | pi, T )p(pi | α)dpi
)K˜−K
=
( α
K˜
∫ 1
0
(1− pi)S(T )pi αK˜−1dpi
)K˜−K
=
[ α
K˜
Beta
( α
K˜
, S(T ) + 1
)]K˜−K
=
[Γ( α
K˜
+ 1)Γ(S(T ) + 1)
Γ( α
K˜
+ S(T ) + 1)
]K˜−K
= exp
[
(K˜ −K) log
(Γ( α
K˜
+ 1)Γ(S(T ) + 1)
Γ( α
K˜
+ S(T ) + 1)
)]
,
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where
log(
Γ( α
K˜
+ 1)Γ(S(T ) + 1)
Γ( α
K˜
+ S(T ) + 1) ) = log(1 +
Γ( α
K˜
+ 1)Γ(S(T ) + 1)− Γ( α
K˜
+ S(T ) + 1)
Γ( α
K˜
+ S(T ) + 1) )
∼Γ(
α
K˜
+ 1)Γ(S(T ) + 1)− Γ( α
K˜
+ S(T ) + 1)
Γ( α
K˜
+ S(T ) + 1)
∼Γ(
α
K˜
+ 1)Γ(S(T ) + 1)− Γ( α
K˜
+ S(T ) + 1)
Γ(S(T ) + 1)
=Γ(
α
K˜
+ 1)− Γ(
α
K˜
+ S(T ) + 1)
Γ(S(T ) + 1) .
Here A(K˜) ∼ B(K˜) means that A(K˜)/B(K˜) → 1 as K˜ → ∞. Recall that ψ(x) = Γ′(x)/Γ(x)
denote the digamma function. We have
Γ(
α
K˜
+ 1)− Γ(
α
K˜
+ S(T ) + 1)
Γ(S(T ) + 1) = − (ψ(S(T ) + 1)− ψ(1))
α
K˜
+ o(
1
K˜
).
Finally,
lim
K˜→∞
P2,K˜(Z˜ | α, T ) = lim
K˜→∞
(∫
P (0 | pi, T )p(pi | α)dpi
)K˜−K
= lim
K˜→∞
exp
[
(K˜ −K) log
(Γ( α
K˜
+ 1)Γ(S(T ) + 1)
Γ( α
K˜
+ S(T ) + 1)
)]
= exp{− (ψ(S(T ) + 1)− ψ(1))α}. (S4)
as K˜ →∞.
Combining equations (S3) and (S4), we get
Π(Z | α, T ) = lim
K˜→∞
ΠK˜(Z | α, T )
= exp{− (ψ(S(T ) + 1)− ψ(1))α}α
K
K!
K∏
k=1
λ(zk, T ),
for Z ∈ Zp.
We then consider Z = 0, in which case Z˜ is a matrix with K˜ all zero columns. We have
ΠK˜(Z | α, T ) =
K˜∏
k=1
∫
P (0 | pik, T )p(pik | α)dpik
=
(∫
P (0 | pi, T )p(pi | α)dpi
)K˜
.
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According to equation (S4), we get
Π(Z | α, T ) = lim
K˜→∞
ΠK˜(Z | α, T )
= exp{− (ψ(S(T ) + 1)− ψ(1))α},
for Z = 0.
To summarize,
Π(Z | α, T ) =

exp{− (ψ(S(T ) + 1)− ψ(1))α}, Z = 0;
exp{− (ψ(S(T ) + 1)− ψ(1))α}αK
K!
K∏
k=1
λ(zk, T ), Z ∈ Zp.
S2 Proof of Lemma 1
For the proof of Lemma 1, we first introduce some definition and notation. We say two leaf nodes
belong to the same subgroup, if they share the same parent node. Let L denote the total number of
subgroups. Denote by nodel the common parent node for subgroup l, Ml the number of leaf nodes
in subgroup l, and ηl the length between nodel and any leaf node in subgroup l, l = 1, . . . , L. We
have p =
∑L
l=1 Ml. Furthermore, denote by mkl the number of leaf nodes in column k that belong
to subgroup l and equal to 1, i.e. mkl =
∑
j∈subgroup l zjk. We have
∑L
l=1mkl = mk. See Figure S1
for an example.
Next, we give a preparatory lemma.
Lemma 2. Consider λk = λ(zk, T ) =
∫ 1
0
P (zk | pik, T )pi−1k dpik (see Equation (S2)). Each λk has
the following lower bound
λk ≥
∫ 1
0
(1− pik)
S(T )−∑
l
ηlmkl∏
l
([1− (1− pik)ηl ]mkl) pi−1k dpik,
where S(T ) denotes the total length of tree structure T (see example in Figure 1).
Proof of Lemma 2. Let Ω denote the event that the variables at all interior nodes of the tree take
value 0. For example, in Figure S1, all interior nodes (in blue and red) should take value 0 (hollow
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circle). We have
P (zk | pik, T ) ≥ P (Ω | pik, T )× P (zk | Ω, pik, T )
= (1− pik)
S(T )−∑
l
ηlMl ×
∏
l
(
[1− (1− pik)ηl ]mkl(1− pik)ηl(Ml−mkl)
)
= (1− pik)
S(T )−∑
l
ηlmkl∏
l
(
[1− (1− pik)ηl ]mkl
)
,
which implies that
λk ≥
∫ 1
0
(1− pik)
S(T )−∑
l
ηlmkl∏
l
([1− (1− pik)ηl ]mkl) pi−1k dpik.
Proof of Lemma 1. For notational simplicity, we omit the index n in K∗n, pn, sn, mkn, Zn, Z
∗
n,
etc., in the following proof. We use C, C1, C2, . . . , C7 to represent positive constants. It suffices
to prove the result for pIBP, as IBP is a special case of pIBP, in which the length between each
leaf node and its parent node (the root) is always 1.
We first consider Z∗ ∈ Zp×K∗ , i.e., none of the columns of Z∗ consist of all 0’s. Based on the
assumption in case (2), ηl ≥ η0, ∀ 1 ≤ l ≤ L and ∀ n. Lemma 2 implies that
λk ≥
∫ 1
0
(1− pik)
S(T )−∑
l
ηlmkl
[1− (1− pik)η0 ]
∑
l
mkl
pi−1k dpik
≥
∫ 1
0
(1− pik)S(T )[1− (1− pik)η0 ]mkpi−1k dpik
(
Let u = (1− pik)1−η0
)
=
∫ 1
0
u
S(T )
1−η0 (1− u)mk(1− u 11−η0 )−1 1
1− η0u
η0
1−η0 du
≥ 1
1− η0
∫ 1
0
uC1S(T )(1− u)mkdu
≥ 1
1− η0
∫ 1
0
uC1p(1− u)mkdu,
for some positive constant C1, considering that S(T ) ≤ p (see Figure S1 for an explanation).
Given mk ≤ s,
∫ 1
0
uC1p(1− u)mkdu ≥ ∫ 1
0
uC1p(1− u)sdu. Thus we have
λk ≥ C2
∫ 1
0
uC1p(1− u)sdu = C2 Beta(C1p+ 1, s+ 1) = C2 Γ(C1p+ 1)Γ(s+ 1)
Γ(C1p+ s+ 2)
.
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By Stirling’s formula, we get
λk ≥C2 Γ(C1p+ 1)Γ(s+ 1)
Γ(C1p+ s+ 2)
∼ C2
√
2piC1p
(
C1p
e
)C1p√
2pis
(
s
e
)s√
2pi(C1p+ s+ 1)
(
C1p+s+1
e
)C1p+s+1
∼ C3 (C1p)
C1pss+
1
2
(C1p+ s+ 1)C1p+s+1
≥ C3
(
C1p
C1p+ s+ 1
)C1p( 1
C1p+ s+ 1
)s+1
,
considering s/p→ 0 and s ≥ 1. Since s/p→ 0, ∃ C4 > 0 and n0 ∈ N+ such that log
(
1− s+1
C1p+s+1
)
≥
−C4 s+1C1p+s+1 as n ≥ n0. So(
C1p
C1p+ s+ 1
)C1p
= exp
(
C1p log
(
1− s+ 1
C1p+ s+ 1
))
≥ exp(−C5s).
Thus,
λk ≥ C3 exp(−C5s)
(
1
C1p+ s+ 1
)s+1
≥ exp(−C6s log(p+ 1)),
for n ≥ n0. And λk ≥ exp(−C6s log(p + 1)) also holds for n < n0 by choosing a sufficiently large
C6.
For pIBP mixture,
Π(Z = Z∗) =
(
ψ
(
S(T ) + 1
)
− ψ(1) + 1
)−(K∗+1) K∗∏
k=1
λk,
and for the digamma function ψ(·), we have
ψ(S(T ) + 1)− ψ(1) + 1 = log(S(T )) +O(1) ≤ log p+O(1).
Therefore,
log(ψ(S(T ) + 1)− ψ(1) + 1) ≤ C7 max{log log(p+ 1), 1}.
Thus,
(ψ(S(T ) + 1)− ψ(1) + 1)−(K∗+1) = exp{−(K∗ + 1) log(ψ(S(T ) + 1)− ψ(1) + 1)}
≥ exp(−2C7K∗max{log log(p+ 1), 1}),
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and we finally have
Π(Z = Z∗) ≥ exp(−2C7K∗max{log log(p+ 1), 1}) (exp(−C6s log(p+ 1)))K
∗
≥ exp(−CsK∗ log(p+ 1)), (S5)
for some positive constant C.
Next, we consider Z∗n = 0. We immediately have
Π(Zn = Z
∗
n) =
(
ψ(S(T ) + 1)− ψ(1) + 1
)−1
≥ exp(−C7 max{log log(p+ 1), 1})
≥ exp(−C log(p+ 1)).
S3 Proof of Theorem 1
For the proof of Theorem 1, we first introduce two preparatory lemmas from the literature.
Lemma 3 (Theorem 1 in Chen et al. 2016). Let Z be a collection of binary matrices that contains
Z∗. Consider a family of probability measures indexed by Z ∈ Z, i.e., {µZ : Z ∈ Z}. For any
subset U of Z and any testing function φ based on X,
EZ∗ [Π(U | X)] ≤ EZ∗(φ) + 1
Π(ZZT = Z∗Z∗T )
sup
Z∈U
EZ(1− φ),
where EZ(·) means taking expectation in the case where X ∼ µZ.
Lemma 4 (Remark 5.40.2 in Vershynin 2012). Suppose that p dimensional random variables
xTi
i.i.d.∼ N(0,Σ) for i = 1, 2, · · · , n and let Σˆ =
n∑
i=1
xTi xi/n denote the sample covariance matrix.
Then for every t ≥ 0,
PΣ(‖Σˆ− Σ‖ ≥ max{δ, δ2}‖Σ‖) ≤ exp(−Ct2),
where δ = C ′
√
p
n
+ t√
n
and C and C ′ are positive constants.
Proof of Theorem 1. Let Σn = ZnZ
T
n + Ipn and Σ
∗
n = Z
∗
nZ
∗T
n + Ipn denote the model covariance
matrix and the true covariance matrix, respectively. For any Z˜∗n ∈ Z˜pn×K˜∗n and Z∗n = G(Z˜∗n) ∈ Z0pn ,
we have
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1. {Zn : ‖ZnZTn − Z˜∗nZ˜∗Tn ‖ ≤ Cn} = {Zn : ‖ZnZTn − Z∗nZ∗Tn ‖ ≤ Cn};
2. EZ˜∗n(·) = EZ∗n(·), considering the binary factor model where
xTi | Z∗n i.i.d∼ N(0, Z∗nZ∗Tn + Ipn).
Based on the above two facts, it suffices to prove for Z∗n ∈ Z0pn . In the following proof, C represents
the positive constant in Theorem 1, and C ′, C1, C2, . . . , C11 represent other positive constants.
We first consider the case that Z∗n ∈ Zpn×K∗n . That is, mkn ≥ 1 for all k = 1, . . . , K∗n and
n = 1, 2, . . .. Recall Lemma 1,
Π(Zn = Z
∗
n) ≥ exp(−C1snK∗n log(pn + 1)). (S6)
Also, recall the assumption
n =
max{√pn,
√
snK∗n log(pn + 1)}√
n
‖Z∗nZ∗Tn ‖ → 0,
as n → ∞. Since ‖Σ∗n‖ = ‖Z∗nZ∗Tn + Ipn‖ = ‖Z∗nZ∗Tn ‖ + 1 ≤ C2‖Z∗nZ∗Tn ‖, the following three
conditions hold:
′n ,
max{√pn,
√
snK∗n log(pn + 1)}√
n
‖Σ∗n‖ → 0, as n→∞; (S7)
pn
n
→ 0, as n→∞; (S8)
snK
∗
n log(pn + 1)
n
→ 0, as n→∞. (S9)
Condition (S7) is due to ′n ≤ C2n → 0 as n → ∞, condition (S8) is due to
√
pn/n ≤√
pn/n
(‖Z∗Z∗T‖+ 1) ≤ ′n → 0 as n→∞, and condition (S9) is due to √snK∗n log(pn + 1)/n ≤√
snK∗n log(pn + 1)/n
(‖Z∗Z∗T‖+ 1) ≤ ′n → 0 as n→∞.
Since C2n ≥ ′n, we can re-write Cn ≥ C ′′n for some positive constant C ′ ≤ C/C2. To show
EZ∗n [Π(‖ZnZTn − Z∗nZ∗Tn ‖ ≤ Cn | X)]→ 1, as n→∞,
it suffices to show
EZ∗n [Π(‖ZnZTn − Z∗nZ∗Tn ‖ ≥ Cn | X)]→ 0, as n→∞,
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or
EZ∗n [Π(‖ZnZTn − Z∗nZ∗Tn ‖ ≥ C ′′n | X)]→ 0, as n→∞.
For notational simplicity, we omit the index n in K∗n, pn, sn, mkn, Zn, Z
∗
n, Σn, Σ
∗
n, etc., in the
following proof. Let
U , {‖ZZT − Z∗Z∗T‖ ≥ C ′′} = {‖Σ− Σ∗‖ ≥ C ′′}. (S10)
Thus,
EZ∗ [Π(U | X)] = EZ∗ [Π(‖ZZT − Z∗Z∗T‖ ≥ C ′′ | X)].
Lemma 3 implies that to show EZ∗ [Π(U | X)]→ 0 as n→∞, it suffices to show 1Π(ZZT=Z∗Z∗T ) sup
Z∈U
EZ(1−
φ)→ 0 and EZ∗φ→ 0 as n→∞, for some testing function φ.
Define the testing function
φ = 1{‖Σˆ−Σ∗‖>C′′
2
}.
We first show lim
n→∞
1
Π(ZZT=Z∗Z∗T ) sup
Z∈U
EZ(1− φ) = 0, where EZ(1− φ) = PΣ(‖Σˆ−Σ∗‖ ≤ C′′2 ). We
consider two scenarios ‖Σ‖ ≥ 2‖Σ∗‖ and ‖Σ‖ < 2‖Σ∗‖ separately.
For ‖Σ‖ ≥ 2‖Σ∗‖,
PΣ(‖Σˆ− Σ∗‖ ≤ C
′′
2
) ≤ PΣ(‖Σˆ− Σ‖ ≥ ‖Σ‖ − ‖Σ∗‖ − C
′′
2
)
= PΣ
(
‖Σˆ− Σ‖
‖Σ‖ ≥ 1−
‖Σ∗‖
‖Σ‖ −
C ′′
2‖Σ‖
)
≤ PΣ
(
‖Σˆ− Σ‖
‖Σ‖ ≥
1
2
− C
′′
2‖Σ‖
)
≤ PΣ
(
‖Σˆ− Σ‖
‖Σ‖ ≥
1
2
− C
′′
4‖Σ∗‖
)
≤ PΣ
(
‖Σˆ− Σ‖
‖Σ‖ ≥
1
2
− C
′′
4
)
.
Since ′ → 0 as n→∞, for sufficiently large n, we have
PΣ
(
‖Σˆ− Σ‖
‖Σ‖ ≥
1
2
− C
′′
4
)
≤ PΣ
(
‖Σˆ− Σ‖
‖Σ‖ ≥
1
4
)
.
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Applying Lemma 4 with t =
√
n/5. Since p/n→ 0 as n→∞, δ = C3
√
p
n
+ t√
n
≤ 1
4
for sufficiently
large n. Thus
PΣ
(
‖Σˆ− Σ‖
‖Σ‖ ≥
1
4
)
≤ PΣ
(
‖Σˆ− Σ‖
‖Σ‖ ≥ max{δ, δ
2}
)
≤ exp(−C4n).
Applying Lemma 1 (S6) and since [sK∗ log(p+ 1)]/n→ 0 as n→∞,
1
Π(ZZT = Z∗Z∗T )
sup
‖Σ‖≥2‖Σ∗‖
PΣ(‖Σˆ− Σ∗‖ ≤ C
′′
2
) ≤ exp(−C4n)
exp(−C1sK∗ log(p+ 1)) → 0,
as n→∞.
Next, we consider ‖Σ‖ ≤ 2‖Σ∗‖. Applying Lemma 4 with t = C5
√
sK∗ log(p+ 1),
PΣ(‖Σˆ− Σ‖ ≥ 2 max{δ, δ2}‖Σ∗‖) ≤ PΣ(‖Σˆ− Σ‖ ≥ max{δ, δ2}‖Σ‖)
≤ exp(−C6C25sK∗ log(p+ 1)),
where δ = C7
√
p
n
+ C5
√
sK∗ log(p+1)
n
. Again, according to Lemma 1 (S6),
1
Π(ZZT = Z∗Z∗T )
sup
‖Σ‖≤2‖Σ∗‖
PΣ(‖Σˆ− Σ‖ ≥ 2 max{δ, δ2}‖Σ∗‖) ≤
exp(−C6C25sK∗ log(p+ 1))
exp(−C1sK∗ log(p+ 1)) → 0,
for a sufficiently large C5 > 0. Due to conditions (S8) and (S9), δ → 0 as n → ∞. Thus, for
sufficiently large n,
max{δ, δ2} = δ ≤ C8
2
· max{
√
p,
√
sK∗ log(p+ 1)}√
n
,
for some positive constant C8, which implies
1
Π(ZZT = Z∗Z∗T )
sup
‖Σ‖≤2‖Σ∗‖
PΣ
(
‖Σˆ− Σ‖ ≥ C8
max{√p,√sK∗ log(p+ 1)}√
n
‖Σ∗‖
)
=
1
Π(ZZT = Z∗Z∗T )
sup
‖Σ‖≤2‖Σ∗‖
PΣ
(
‖Σˆ− Σ‖ ≥ C8′
)
→ 0,
as n → ∞. Recall that φ is the indicator function 1{‖Σˆ−Σ∗‖>C′′
2
} and U = {‖Σ− Σ∗‖ ≥ C ′′} as
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in (S10). By choosing C ′ ≥ 2C8, we have
1
Π(ZZT = Z∗Z∗T )
sup
Z∈U, ‖Σ‖≤2‖Σ∗‖
EZ(1− φ)
=
1
Π(ZZT = Z∗Z∗T )
sup
Z∈U, ‖Σ‖≤2‖Σ∗‖
PΣ
(
‖Σˆ− Σ∗‖ ≤ C
′′
2
)
≤ 1
Π(ZZT = Z∗Z∗T )
sup
‖Σ‖≤2‖Σ∗‖
PΣ
(
‖Σˆ− Σ‖ ≥ C
′′
2
)
≤ 1
Π(ZZT = Z∗Z∗T )
sup
‖Σ‖≤2‖Σ∗‖
PΣ
(
‖Σˆ− Σ‖ ≥ C8′
)
→ 0,
as n→∞.
Combining the results for ‖Σ‖ ≥ 2‖Σ∗‖ and ‖Σ‖ ≤ 2‖Σ∗‖, we have proved
1
Π(ZZT = Z∗Z∗T )
sup
Z∈U
EZ(1− φ)→ 0, (S11)
as n→∞, for C ′ ≥ 2C8.
Next, it remains to show lim
n→∞
EZ∗φ = 0.
Applying Lemma 4 with t =
√
p and δ = C9
√
p
n
+ t√
n
= C10
√
p
n
. Due to condition (S8), δ → 0
as n→∞. Thus, max{δ, δ2} = δ = C10
√
p
n
for sufficiently large n and
PΣ∗
(
‖Σˆ− Σ∗‖ ≥ C10
√
p
n
‖Σ∗‖
)
= PΣ∗(‖Σˆ− Σ∗‖ ≥ max{δ, δ2}‖Σ∗‖) ≤ exp(−C11p)→ 0,
as n→∞.
Since ′ =
max{√p,
√
sK∗ log(p+1)}√
n
‖Σ∗‖ ≥√ p
n
‖Σ∗‖, we have
EZ∗φ = PΣ∗
(
‖Σˆ− Σ∗‖ > C
′′
2
)
≤ PΣ∗
(
‖Σˆ− Σ∗‖ ≥ C10
√
p
n
‖Σ∗‖
)
→ 0 (S12)
as n→∞, for C ′ ≥ 2C10.
Combining results in (S11) and (S12), by Lemma 3, we have
EZ∗ [Π(‖ZZT − Z∗Z∗T‖ ≥ C ′′ | X)]→ 0, as n→∞,
for C ′ ≥ 2 max{C8, C10}. By choosing C ≥ C ′C2 we have
EZ∗ [Π(‖ZZT − Z∗Z∗T‖ ≥ C | X)]→ 0, as n→∞.
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The proof for Z∗ ∈ Zp×K∗ is now complete.
Next, we consider Z∗ = 0, in which situation  =
max{√p,
√
log(p+1)}√
n
.
Lemma 1 ensures that
Π(Z = Z∗) ≥ exp(−C log(p+ 1)).
Similar to the proof for Z∗ ∈ Zp×K∗ , if → 0 as n→∞, then
EZ∗
[
Π
(‖ZZT − Z∗Z∗T‖ ≤ C | X)]→ 1,
as n→∞ for some positive constant C. The proof is now complete.
S4 Proof of Corollary 1
Proof of Corollary 1. For notational simplicity, we omit the index n. Let Z∗ = (z1, z2, · · · , zp)T ,
then Z∗Z∗T = (zTa zb)p×p. We have
‖Z∗Z∗T‖ ≤ sup
1≤a≤p
( p∑
b=1
zTa zb
)
.
For each a,
p∑
b=1
zTa zb represents the total number of features shared by object a and all the
other objects. If za has at most q non-zero entries and each column of Z
∗ has at most s non-zero
entries, then
p∑
b=1
zTa zb ≤ sq,
for every a, which implies that
‖Z∗Z∗T‖ ≤ sq,
Since s, q ≥ 1, we immediately have
 =
max{√p,√sK∗ log(p+ 1)}√
n
max{1, ‖Z∗Z∗T‖} ≤ ˜ = max{
√
p,
√
sK∗ log(p+ 1)}√
n
sq.
Thus, ˜ → 0 implies  → 0 (as n → ∞). According to Theorem 1, we have EZ∗ [Π(‖ZZT −
Z∗Z∗T‖ ≤ C | X)]→ 1. Therefore
EZ∗ [Π(‖ZZT − Z∗Z∗T‖ ≥ C˜ | X)] ≤ EZ∗ [Π(‖ZZT − Z∗Z∗T‖ ≥ C | X)]→ 0,
as n→∞, i.e. EZ∗ [Π(‖ZZT−Z∗Z∗T‖ ≤ C˜ | X)]→ 1, meaning that ˜ is the posterior contraction
rate given ˜→ 0 as n→ 0. Specifically,
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1. if there is no contraint on the total number of active features in each row, then we set q = K∗,
meaning that ˜ =
max{√p,
√
sK∗ log(p+1)}√
n
sK∗ is a valid posterior contraction rate given ˜ → 0
as n→∞;
2. if q is bounded or fixed, then ˜ =
max{√p,
√
sK∗ log(p+1)}√
n
s is a valid posterior contraction rate
given ˜→ 0 as n→∞.
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S5 Supplementary Tables
Table S1: Genes (gene symbol:entrez id) associated with the top 10 proteins with the largest
loadings for the 5 most popular features. A X means the gene is included in the feature.
Gene 1 2 3 4 5 Count
TSC2:7249 X X 2
DIRAS3:9077 X X 2
BAX:581 X X 2
GSK3A:2931 X X 2
AKT1:207 X X 2
ABL1:25 X 1
ARAF:369 X 1
BID:637 X 1
CASP7:840 X 1
DIABLO:56616 X 1
EEF2K:29904 X 1
EIF4EBP1:1978 X 1
RB1:5925 X 1
RPS6KB1:6198 X 1
JAK2:3717 X 1
MYH9:4627 X 1
NRAS:4893 X 1
PREX1:57580 X 1
PTEN:5728 X 1
SRSF1:6426 X 1
STAT3:6774 X 1
STAT5A:6776 X 1
STMN1:3925 X 1
ANXA7:310 X 1
COPS5:10987 X 1
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ERCC5:2073 X 1
IRF1:3659 X 1
ITGA2:3673 X 1
TFRC:7037 X 1
YWHAB:7529 X 1
BRD4:23476 X 1
EIF4G1:1981 X 1
MAPK9:5601 X 1
MRE11:4361 X 1
NFKB1:4790 X 1
PRKCA:5578 X 1
RBM15:64783 X 1
BCL2:596 X 1
BCL2L11:10018 X 1
ERRFI1:54206 X 1
MAP2K1:5604 X 1
MAPK1:5594 X 1
YBX1:4904 X 1
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Table S2: Pathways that the top genes of the first 5 features are enriched in. Each cell shows the genes (gene symbol:entrez
id) of each feature that are enriched in the corresponding pathway.
Group Pathways 1 2 3 4 5 Count
Cancer Pathways in
cancer
ABL1:25,
ARAF:369,
RB1:5925,
BID:637
NRAS:4893,
PTEN:5728,
STAT3:6774,
STAT5A:6776
ITGA2:3673,
BAX:581
AKT1:207,
NFKB1:4790,
PRKCA:5578,
MAPK9:5601,
BAX:581
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
5
PI3K PI3K-Akt
signaling
pathway
EIF4EBP1:1978,
RPS6KB1:6198,
TSC2:7249
JAK2:3717,
NRAS:4893,
PTEN:5728
ITGA2:3673,
YWHAB:7529
AKT1:207,
NFKB1:4790,
PRKCA:5578,
TSC2:7249
BCL2L11:10018,
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
5
Cancer Prostate
cancer
ARAF:369,
RB1:5925
NRAS:4893,
PTEN:5728
– AKT1:207,
NFKB1:4790
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
4
Cancer Chronic
myeloid
leukemia
ABL1:25,
ARAF:369,
RB1:5925
NRAS:4893,
STAT5A:6776
– AKT1:207,
NFKB1:4790
AKT1:207,
MAPK1:5594,
MAP2K1:5604
4
Cancer Glioma ARAF:369,
RB1:5925
NRAS:4893,
PTEN:5728
– AKT1:207,
PRKCA:5578
AKT1:207,
MAPK1:5594,
MAP2K1:5604
4
40
Cancer Non-small
cell lung
cancer
ARAF:369,
RB1:5925
NRAS:4893,
STAT3:6774,
STAT5A:6776
– AKT1:207,
PRKCA:5578
AKT1:207,
MAPK1:5594,
MAP2K1:5604
4
Cancer Acute
myeloid
leukemia
EIF4EBP1:1978,
ARAF:369,
RPS6KB1:6198
NRAS:4893,
STAT3:6774,
STAT5A:6776
– AKT1:207,
NFKB1:4790
AKT1:207,
MAPK1:5594,
MAP2K1:5604
4
PI3K mTOR
signaling
pathway
EIF4EBP1:1978,
RPS6KB1:6198,
TSC2:7249
NRAS:4893,
PTEN:5728
– AKT1:207,
PRKCA:5578,
TSC2:7249
AKT1:207,
MAPK1:5594,
MAP2K1:5604
4
PI3K ErbB
signaling
pathway
EIF4EBP1:1978,
ABL1:25,
ARAF:369,
RPS6KB1:6198
NRAS:4893,
STAT5A:6776
– AKT1:207,
PRKCA:5578,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
4
– Non-alcoholic
fatty liver
disease
(NAFLD)
BID:637,
CASP7:840
– GSK3A:2931,
BAX:581
AKT1:207,
NFKB1:4790,
MAPK9:5601,
BAX:581
BCL2L11:10018,
AKT1:207,
GSK3A:2931
4
– Regulation of
autophagy
RPS6KB1:6198,
TSC2:7249
NRAS:4893,
PTEN:5728
– AKT1:207,
MAPK9:5601,
TSC2:7249
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
4
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– Proteoglycans
in cancer
ARAF:369,
RPS6KB1:6198
NRAS:4893,
STAT3:6774
– AKT1:207,
PRKCA:5578
AKT1:207,
MAPK1:5594,
MAP2K1:5604
4
– Hepatitis B – NRAS:4893,
PTEN:5728,
STAT3:6774,
STAT5A:6776
BAX:581,
YWHAB:7529
AKT1:207,
NFKB1:4790,
PRKCA:5578,
MAPK9:5601,
BAX:581
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
4
Cancer Melanoma ARAF:369,
RB1:5925
NRAS:4893,
PTEN:5728
– – AKT1:207,
MAPK1:5594,
MAP2K1:5604
3
Cancer Pancreatic
cancer
ARAF:369,
RB1:5925
– – AKT1:207,
NFKB1:4790,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
3
PI3K Insulin
signaling
pathway
EIF4EBP1:1978,
ARAF:369,
RPS6KB1:6198,
TSC2:7249
– – AKT1:207,
MAPK9:5601,
TSC2:7249
AKT1:207,
MAPK1:5594,
MAP2K1:5604
3
PI3K Apoptosis DIABLO:56616,
BID:637,
CASP7:840
– – AKT1:207,
NFKB1:4790,
MAPK9:5601,
BAX:581
BCL2L11:10018,
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
3
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PI3K Chemokine
signaling
pathway
– JAK2:3717,
NRAS:4893,
PREX1:57580,
STAT3:6774
– AKT1:207,
NFKB1:4790
AKT1:207,
GSK3A:2931,
MAPK1:5594,
MAP2K1:5604
3
PI3K FoxO
signaling
pathway
– NRAS:4893,
PTEN:5728,
STAT3:6774
– AKT1:207,
MAPK9:5601
BCL2L11:10018,
AKT1:207,
MAPK1:5594,
MAP2K1:5604
3
PI3K MAPK
signaling
pathway
– STMN1:3925,
NRAS:4893
– AKT1:207,
NFKB1:4790,
PRKCA:5578,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
3
– HIF-1
signaling
pathway
EIF4EBP1:1978,
RPS6KB1:6198
– – AKT1:207,
NFKB1:4790,
PRKCA:5578
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
3
– Choline
metabolism
in cancer
EIF4EBP1:1978,
RPS6KB1:6198,
TSC2:7249
– – AKT1:207,
PRKCA:5578,
MAPK9:5601,
TSC2:7249
AKT1:207,
MAPK1:5594,
MAP2K1:5604
3
– Viral carcino-
genesis
– NRAS:4893,
STAT3:6774,
STAT5A:6776
BAX:581,
YWHAB:7529
NFKB1:4790,
BAX:581
– 3
43
– Cholinergic
synapse
– JAK2:3717,
NRAS:4893
– AKT1:207,
PRKCA:5578
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
3
– Prolactin
signaling
pathway
– JAK2:3717,
NRAS:4893,
STAT3:6774,
STAT5A:6776
– AKT1:207,
NFKB1:4790,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
3
– Toxoplas-
mosis
– JAK2:3717,
STAT3:6774
– AKT1:207,
NFKB1:4790,
MAPK9:5601
AKT1:207,
MAPK1:5594,
BCL2:596
3
– Sphingolipid
signaling
pathway
– NRAS:4893,
PTEN:5728
– AKT1:207,
NFKB1:4790,
PRKCA:5578,
MAPK9:5601,
BAX:581
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
3
– MicroRNAs
in cancer
– STMN1:3925,
NRAS:4893,
PTEN:5728,
STAT3:6774
– NFKB1:4790,
PRKCA:5578
BCL2L11:10018,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
3
– Hepatitis C – NRAS:4893,
STAT3:6774
– AKT1:207,
NFKB1:4790,
MAPK9:5601
AKT1:207,
MAPK1:5594
3
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Cancer Bladder
cancer
ARAF:369,
RB1:5925
– – – MAPK1:5594,
MAP2K1:5604
2
Cancer Endometrial
cancer
– NRAS:4893,
PTEN:5728
– – AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
Cancer Colorectal
cancer
– – – AKT1:207,
MAPK9:5601,
BAX:581
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
2
Cancer Small cell
lung cancer
– – – AKT1:207,
NFKB1:4790
AKT1:207,
BCL2:596
2
PI3K p53 signaling
pathway
BID:637,
TSC2:7249
– – BAX:581,
TSC2:7249
– 2
PI3K Jak-STAT
signaling
pathway
– JAK2:3717,
STAT3:6774,
STAT5A:6776
– – AKT1:207,
BCL2:596
2
PI3K Focal
adhesion
– – – AKT1:207,
PRKCA:5578,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
2
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PI3K B cell
receptor
signaling
pathway
– – – AKT1:207,
NFKB1:4790
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
PI3K Toll-like
receptor
signaling
pathway
– – – AKT1:207,
NFKB1:4790,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
PI3K VEGF
signaling
pathway
– – – AKT1:207,
PRKCA:5578
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– AMPK
signaling
pathway
EIF4EBP1:1978,
EEF2K:29904,
RPS6KB1:6198,
TSC2:7249
– – AKT1:207,
TSC2:7249
– 2
– Natural killer
cell mediated
cytotoxicity
ARAF:369,
BID:637
– – – MAPK1:5594,
MAP2K1:5604
2
– HTLV-I
infection
– NRAS:4893,
STAT5A:6776
– AKT1:207,
NFKB1:4790,
BAX:581
– 2
46
– Measles – JAK2:3717,
STAT3:6774,
STAT5A:6776
– AKT1:207,
NFKB1:4790
– 2
– Herpes
simplex
infection
– JAK2:3717,
SRSF1:6426
– NFKB1:4790,
MAPK9:5601
– 2
– Adipocytokine
signaling
pathway
– JAK2:3717,
STAT3:6774
– AKT1:207,
NFKB1:4790,
MAPK9:5601
– 2
– Signaling
pathways
regulating
pluripotency
of stem cells
– JAK2:3717,
NRAS:4893,
STAT3:6774
– – AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– Regulation of
actin
cytoskeleton
– MYH9:4627,
NRAS:4893
– – MAPK1:5594,
MAP2K1:5604
2
– Central
carbon
metabolism
in cancer
– NRAS:4893,
PTEN:5728
– – AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
47
– Epstein-Barr
virus
infection
– – – AKT1:207,
NFKB1:4790,
MAPK9:5601
AKT1:207,
BCL2:596
2
– TNF
signaling
pathway
– – – AKT1:207,
NFKB1:4790,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– Tuberculosis – – – AKT1:207,
NFKB1:4790,
MAPK9:5601,
BAX:581
AKT1:207,
MAPK1:5594,
BCL2:596
2
– Neurotrophin
signaling
pathway
– – – AKT1:207,
NFKB1:4790,
MAPK9:5601,
BAX:581
AKT1:207,
MAPK1:5594,
MAP2K1:5604,
BCL2:596
2
– Ras signaling
pathway
– – – AKT1:207,
NFKB1:4790,
PRKCA:5578,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– Adrenergic
signaling in
cardiomy-
ocytes
– – – AKT1:207,
PRKCA:5578
AKT1:207,
MAPK1:5594,
BCL2:596
2
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– Thyroid
hormone
signaling
pathway
– – – AKT1:207,
PRKCA:5578,
TSC2:7249
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– Progesterone-
mediated
oocyte
maturation
– – – AKT1:207,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– Chagas
disease
(American
trypanosomi-
asis)
– – – AKT1:207,
NFKB1:4790,
MAPK9:5601
AKT1:207,
MAPK1:5594
2
– Osteoclast
differentia-
tion
– – – AKT1:207,
NFKB1:4790,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– T cell
receptor
signaling
pathway
– – – AKT1:207,
NFKB1:4790,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– cAMP
signaling
pathway
– – – AKT1:207,
NFKB1:4790,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
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– Influenza A – – – AKT1:207,
NFKB1:4790,
PRKCA:5578,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– Fc gamma
R-mediated
phagocytosis
– – – AKT1:207,
PRKCA:5578
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– Rap1
signaling
pathway
– – – AKT1:207,
PRKCA:5578
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– Dopaminergic
synapse
– – – AKT1:207,
PRKCA:5578,
MAPK9:5601
AKT1:207,
GSK3A:2931
2
– Fc epsilon RI
signaling
pathway
– – – AKT1:207,
PRKCA:5578,
MAPK9:5601
AKT1:207,
MAPK1:5594,
MAP2K1:5604
2
– NOD-like
receptor
signaling
pathway
– – – NFKB1:4790,
MAPK9:5601
MAPK1:5594,
BCL2:596
2
– GnRH
signaling
pathway
– – – PRKCA:5578,
MAPK9:5601
MAPK1:5594,
MAP2K1:5604
2
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Cancer Renal cell
carcinoma
– – – – AKT1:207,
MAPK1:5594,
MAP2K1:5604
1
Cancer Thyroid
cancer
– – – – MAPK1:5594,
MAP2K1:5604
1
PI3K Cell cycle ABL1:25,
RB1:5925
– – – – 1
– Viral
myocarditis
ABL1:25,
BID:637
– – – – 1
– Alzheimer’s
disease
BID:637,
CASP7:840
– – – – 1
– Hematopoietic
cell lineage
– – ITGA2:3673,
TFRC:7037
– – 1
– Phagosome – – ITGA2:3673,
TFRC:7037
– – 1
– Protein
processing in
endoplasmic
reticulum
– – – MAPK9:5601,
BAX:581
– 1
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– Epithelial cell
signaling in
Helicobacter
pylori
infection
– – – NFKB1:4790,
MAPK9:5601
– 1
– Pertussis – – – NFKB1:4790,
MAPK9:5601
– 1
– RIG-I-like
receptor
signaling
pathway
– – – NFKB1:4790,
MAPK9:5601
– 1
– Salmonella
infection
– – – NFKB1:4790,
MAPK9:5601
– 1
– Shigellosis – – – NFKB1:4790,
MAPK9:5601
– 1
– Amoebiasis – – – NFKB1:4790,
PRKCA:5578
– 1
– Inflammatory
mediator
regulation of
TRP
channels
– – – PRKCA:5578,
MAPK9:5601
– 1
52
– Retrograde
endocannabi-
noid
signaling
– – – PRKCA:5578,
MAPK9:5601
– 1
– Wnt
signaling
pathway
– – – PRKCA:5578,
MAPK9:5601
– 1
– Platelet
activation
– – – – AKT1:207,
MAPK1:5594
1
– cGMP-PKG
signaling
pathway
– – – – AKT1:207,
MAPK1:5594,
MAP2K1:5604
1
– Alcoholism – – – – MAPK1:5594,
MAP2K1:5604
1
– Dorso-ventral
axis
formation
– – – – MAPK1:5594,
MAP2K1:5604
1
– Gap junction – – – – MAPK1:5594,
MAP2K1:5604
1
– Long-term
depression
– – – – MAPK1:5594,
MAP2K1:5604
1
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– Long-term
potentiation
– – – – MAPK1:5594,
MAP2K1:5604
1
– Melanogenesis – – – – MAPK1:5594,
MAP2K1:5604
1
– Oxytocin
signaling
pathway
– – – – MAPK1:5594,
MAP2K1:5604
1
– Prion
diseases
– – – – MAPK1:5594,
MAP2K1:5604
1
– Serotonergic
synapse
– – – – MAPK1:5594,
MAP2K1:5604
1
– Vascular
smooth
muscle
contraction
– – – – MAPK1:5594,
MAP2K1:5604
1
– Estrogen
signaling
pathway
– – – – AKT1:207,
MAPK1:5594,
MAP2K1:5604
1
– Oocyte
meiosis
– – – – MAPK1:5594,
MAP2K1:5604
1
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